Invention Grant
- Patent Title: Compounds for the treatment of cancer
-
Application No.: US15851188Application Date: 2017-12-21
-
Publication No.: US11066400B2Publication Date: 2021-07-20
- Inventor: Friedrich Metzger , Hasane Ratni
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Zong-Qiang Bill Tian
- Priority: EP15154342 20150209,EP15155286 20150216
- Main IPC: C07D417/14
- IPC: C07D417/14 ; A61K31/433 ; A61K31/435 ; A61K31/4353 ; A61K31/437 ; A61K31/438 ; A61K31/4436 ; A61K31/454 ; A61K31/4545 ; A61K31/4709 ; A61K31/501 ; A61K31/502 ; A61K31/506 ; A61K31/5377 ; A61K31/551 ; A61K45/06 ; C07D401/12 ; C07D401/14 ; A61P35/00
Abstract:
The present invention relates to a FoxM1 gene splicing modifier selected from a compound of formula (I) or of formula (VI) wherein A and B are as defined herein, or a pharmaceutically acceptable salt thereof, for use in the treatment, prevention and/or delay of progression of cancer.
Public/Granted literature
- US20180170923A1 COMPOUNDS FOR THE TREATMENT OF CANCER Public/Granted day:2018-06-21
Information query
